DK1223973T3 - Fremgangsmåde til at udtrykke antigener på overfladen af antigenpræsenterede celler ved fotokemisk internalisation - Google Patents

Fremgangsmåde til at udtrykke antigener på overfladen af antigenpræsenterede celler ved fotokemisk internalisation

Info

Publication number
DK1223973T3
DK1223973T3 DK00909489T DK00909489T DK1223973T3 DK 1223973 T3 DK1223973 T3 DK 1223973T3 DK 00909489 T DK00909489 T DK 00909489T DK 00909489 T DK00909489 T DK 00909489T DK 1223973 T3 DK1223973 T3 DK 1223973T3
Authority
DK
Denmark
Prior art keywords
antigen presented
expressing antigens
photochemical internalization
presented cells
cells
Prior art date
Application number
DK00909489T
Other languages
Danish (da)
English (en)
Inventor
Torunn E Tjelle
Anders Hogset
Lina Prasmickaite
Kristian Berg
Original Assignee
Pci Biotech As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pci Biotech As filed Critical Pci Biotech As
Application granted granted Critical
Publication of DK1223973T3 publication Critical patent/DK1223973T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00909489T 1999-03-15 2000-03-10 Fremgangsmåde til at udtrykke antigener på overfladen af antigenpræsenterede celler ved fotokemisk internalisation DK1223973T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9905911.5A GB9905911D0 (en) 1999-03-15 1999-03-15 Method
PCT/GB2000/000903 WO2000054802A2 (en) 1999-03-15 2000-03-10 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization

Publications (1)

Publication Number Publication Date
DK1223973T3 true DK1223973T3 (da) 2009-05-04

Family

ID=10849643

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00909489T DK1223973T3 (da) 1999-03-15 2000-03-10 Fremgangsmåde til at udtrykke antigener på overfladen af antigenpræsenterede celler ved fotokemisk internalisation

Country Status (19)

Country Link
US (2) US8216587B1 (ja)
EP (1) EP1223973B1 (ja)
JP (1) JP4922490B2 (ja)
KR (1) KR100769113B1 (ja)
CN (1) CN100379450C (ja)
AT (1) ATE419866T1 (ja)
AU (1) AU771990B2 (ja)
CA (1) CA2367357C (ja)
CZ (1) CZ299370B6 (ja)
DE (1) DE60041347D1 (ja)
DK (1) DK1223973T3 (ja)
ES (1) ES2319255T3 (ja)
GB (1) GB9905911D0 (ja)
HU (1) HU227604B1 (ja)
MX (1) MXPA01009316A (ja)
NO (1) NO331101B1 (ja)
NZ (1) NZ514228A (ja)
PL (1) PL208221B1 (ja)
WO (1) WO2000054802A2 (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1339862T3 (en) * 2000-11-29 2014-02-17 Pci Biotech As PHOTO CHEMICAL INTERNALISATION VIRUS-MEDIATED MOLECULAR-DELIVERY INTO cytosol
CZ301427B6 (cs) * 2000-11-29 2010-02-24 Pci Biotech As Zpusob zavedení molekuly do cytosolu bunky
US20030031655A1 (en) * 2001-02-08 2003-02-13 Sequitur, Inc. Methods of light activated release of ligands from endosomes
GB0121023D0 (en) 2001-08-30 2001-10-24 Norwegian Radium Hospital Res Compound
CA2475003A1 (en) 2002-02-01 2003-08-07 Sequitur, Inc. Double-stranded oligonucleotides
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
GB0613753D0 (en) 2006-07-11 2006-08-23 Norwegian Radium Hospital Res Method
AU2007307206B2 (en) * 2006-10-04 2016-02-11 Janssen Pharmaceutica, N.V. Preparation of inactivated artificial antigen presenting cells and their use in cell therapies
GB0811955D0 (en) * 2008-06-30 2008-07-30 Pci Biotech As Method
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
GB0914286D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Method
GB201208548D0 (en) 2012-05-15 2012-06-27 Pci Biotech As Compound and method
US20160040128A1 (en) * 2013-03-15 2016-02-11 Pci Biotech As Method
WO2015028575A1 (en) * 2013-08-28 2015-03-05 Pci Biotech As Immunisation method by photochemical internalisation
CN105873585A (zh) * 2013-08-28 2016-08-17 Pci生物技术公司 用于疫苗接种或免疫的化合物和方法
GB2517707B (en) * 2013-08-28 2020-09-02 Pci Biotech As A device for light-induced rupture of endocytic vesicles to effect the delivery of an antigen
US10973896B2 (en) * 2014-04-11 2021-04-13 Pci Biotech As Treatment or prevention of melanoma using photochemical internalization of a melanoma antigen
NZ729408A (en) 2014-08-28 2021-12-24 Pci Biotech As A method of photochemical internalization (pci) utilizing a antigenic molecule, a photosensitizing agent, and a cytokine
GB201415250D0 (en) * 2014-08-28 2014-10-15 Pci Biotech As Compound and method
GB201503776D0 (en) 2015-03-05 2015-04-22 Pci Biotech As Compound and method
DK3525783T3 (da) 2016-10-14 2021-01-18 Pci Biotech As Behandling af cholangiocarcinom med tpcs-2a-induceret fotokemisk internalisering af gemcitabin
CN107029236B (zh) * 2017-04-18 2020-04-10 中国医学科学院生物医学工程研究所 一种吲哚菁绿自组装纳米疫苗及制备方法
CN107217041B (zh) * 2017-07-11 2020-05-15 深圳华云生物技术有限公司 具有高抗原呈递的dc细胞和抗原特异性t细胞及其制备方法和应用
GB201718631D0 (en) 2017-11-10 2017-12-27 Pci Biotech As Method
JP2021531345A (ja) 2018-07-16 2021-11-18 ディーシープライム・ベスローテン・フェンノートシャップDcprime B.V. 腫瘍ワクチン接種に用いるための組合せ製品
WO2020217226A1 (en) 2019-04-25 2020-10-29 Dcprime B.V. Methods of tumor vaccination
WO2021191871A1 (en) 2020-03-27 2021-09-30 Dcprime B.V. In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
CN115916963A (zh) 2020-03-27 2023-04-04 门德斯有限公司 白血病来源的经修饰细胞用于增强过继性细胞治疗的效力的离体用途
GB202101726D0 (en) 2021-02-08 2021-03-24 Pci Biotech As Method
GB202115451D0 (en) 2021-10-27 2021-12-08 Pci Biotech As Method
GB202301312D0 (en) 2023-01-30 2023-03-15 Pci Biotech As Method and product

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258453A (en) 1992-01-21 1993-11-02 University Of Utah Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light
US20020168374A1 (en) 1992-08-07 2002-11-14 Ralph T. Kubo Hla binding peptides and their uses
US5651993A (en) 1992-11-18 1997-07-29 Yale University Specific immune system modulation
US5820872A (en) * 1992-11-18 1998-10-13 Yale University Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor
NO180167C (no) * 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US6008211A (en) * 1995-07-27 1999-12-28 Pdt Pharmaceuticals, Inc. Photoactivatable compounds comprising benzochlorin and furocoumarin
JP3378889B2 (ja) * 1997-05-07 2003-02-17 キューエルティー インコーポレイテッド 光活性薬剤としてのモノヒドロベンゾポルフィリン誘導体のエチレングリコールエステル
CZ301427B6 (cs) 2000-11-29 2010-02-24 Pci Biotech As Zpusob zavedení molekuly do cytosolu bunky
GB201208548D0 (en) 2012-05-15 2012-06-27 Pci Biotech As Compound and method
CN105873585A (zh) 2013-08-28 2016-08-17 Pci生物技术公司 用于疫苗接种或免疫的化合物和方法

Also Published As

Publication number Publication date
JP2002541072A (ja) 2002-12-03
US9737594B2 (en) 2017-08-22
WO2000054802A3 (en) 2002-05-10
NO20014491L (no) 2001-11-14
NZ514228A (en) 2004-01-30
CN100379450C (zh) 2008-04-09
MXPA01009316A (es) 2003-07-14
AU771990B2 (en) 2004-04-08
ES2319255T3 (es) 2009-05-06
EP1223973B1 (en) 2009-01-07
PL355015A1 (en) 2004-03-22
KR20010110664A (ko) 2001-12-13
HU227604B1 (en) 2011-09-28
KR100769113B1 (ko) 2007-10-22
NO20014491D0 (no) 2001-09-14
HUP0202441A3 (en) 2004-07-28
US8216587B1 (en) 2012-07-10
NO331101B1 (no) 2011-10-03
ATE419866T1 (de) 2009-01-15
HUP0202441A2 (en) 2002-10-28
WO2000054802A2 (en) 2000-09-21
JP4922490B2 (ja) 2012-04-25
CA2367357C (en) 2015-01-06
CZ20013328A3 (cs) 2002-03-13
CZ299370B6 (cs) 2008-07-09
AU3177100A (en) 2000-10-04
CN1376073A (zh) 2002-10-23
CA2367357A1 (en) 2000-09-21
GB9905911D0 (en) 1999-05-05
DE60041347D1 (de) 2009-02-26
EP1223973A2 (en) 2002-07-24
US20130330363A1 (en) 2013-12-12
PL208221B1 (pl) 2011-03-31

Similar Documents

Publication Publication Date Title
DK1223973T3 (da) Fremgangsmåde til at udtrykke antigener på overfladen af antigenpræsenterede celler ved fotokemisk internalisation
DK121683A (da) Fremgangsmaade til fremstilling af immunoenzymatiske konjugater
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
BR9809656A (pt) Composição imunopotencializante
ATE149841T1 (de) Impfstoffe gegen krebs und infektionskrankheiten
DK1028749T3 (da) Enterococcus-antigener og -vacciner
DE69834921D1 (de) Antigen enthaltende zusammensetzung, die zusätzlich derivatisierte monoglyceride oder diglyceride als adjuvantien enthält
DK1066060T3 (da) Mesenkymale stamceller som immunsuppresive midler
FI924819A0 (fi) Chimaera anti-icam-i-antikroppar foer maenniskobruk, foerfaranden foer deras framstaellning samt deras anvaendning
DK1089760T3 (da) Kunstige T-hjælpecelleepitoper som immunstimulatorer for syntetiske peptidimmunogener
BRPI0012196B8 (pt) artigo industrializado
ATE328611T1 (de) Multiple,kohlenhydrathaltige glycopeptid-antigene,daraus entwickelte impfstoffe sowie deren verwendung
AU1248583A (en) Conjugates of muramyl-peptides and haptenes
TR200102034T2 (tr) Anti kanser aşılaması için antikorların kullanılması
ATE457318T1 (de) Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper
UY26266A1 (es) Antigeno asociado con tumores (r11) ley 17164
DE69833455D1 (de) Methoden und zusammensetzungen zur erhöhung der immunantwort und zur herstellung von in-vitro monoklonalen antikörpern (mabs)
ATE359821T1 (de) Bor-neutronenfangtherapie unter verwendung von pre-targeting-methoden
WO2000073432A3 (en) Activation of dendritic cells to enhance immunity
ATE145335T1 (de) Kreuzreaktive immunisierung gegen influenza
IT1289489B1 (it) Assorbitore dell'energia negativa generata da un impatto con il terreno,in specie per sedili di aeromobili
ATE343596T1 (de) Humane monoklonale antikörper gegen inselzellantigen ia-2